Matches in DBpedia 2016-04 for { <http://dbpedia.org/resource/Insulin_glulisine> ?p ?o }
Showing triples 1 to 76 of
76
with 100 triples per page.
- Insulin_glulisine abstract "Insulin glulisine is a rapid-acting insulin analogue that differs from human insulin in that the amino acid asparagine at position B3 is replaced by lysine and the lysine in position B29 is replaced by glutamic acid. It was developed by Sanofi-Aventis and sold under the trade name Apidra. When injected subcutaneously, it appears in the blood earlier than human insulin. When used as a meal time insulin, the dose is given within 15 minutes before a meal or within 20 minutes after starting a meal. Intravenous injections may also be used for extreme hyperglycemia, but must be performed under the supervision of a medical professional.".
- Insulin_glulisine atcPrefix "A10".
- Insulin_glulisine atcSuffix "AB06".
- Insulin_glulisine casNumber "207748-29-6".
- Insulin_glulisine drugbank "DB01309".
- Insulin_glulisine fdaUniiCode "7XIY785AZD".
- Insulin_glulisine wikiPageExternalLink apidra.html.
- Insulin_glulisine wikiPageID "9756329".
- Insulin_glulisine wikiPageLength "3032".
- Insulin_glulisine wikiPageOutDegree "7".
- Insulin_glulisine wikiPageRevisionID "691441090".
- Insulin_glulisine wikiPageWikiLink Asparagine.
- Insulin_glulisine wikiPageWikiLink Category:Insulin_therapies.
- Insulin_glulisine wikiPageWikiLink Glutamic_acid.
- Insulin_glulisine wikiPageWikiLink Insulin.
- Insulin_glulisine wikiPageWikiLink Insulin_analog.
- Insulin_glulisine wikiPageWikiLink Lysine.
- Insulin_glulisine wikiPageWikiLink Sanofi.
- Insulin_glulisine wikiPageWikiLinkText "Apidra".
- Insulin_glulisine wikiPageWikiLinkText "Insulin glulisine".
- Insulin_glulisine wikiPageWikiLinkText "glulisine".
- Insulin_glulisine wikiPageWikiLinkText "insulin glulisine".
- Insulin_glulisine atcPrefix "A10".
- Insulin_glulisine atcSuffix "AB06".
- Insulin_glulisine c "258".
- Insulin_glulisine casNumber "207748".
- Insulin_glulisine chemspiderid "none".
- Insulin_glulisine drugbank "DB01309".
- Insulin_glulisine h "384".
- Insulin_glulisine kegg "D04540".
- Insulin_glulisine legalUk "POM".
- Insulin_glulisine legalUs "Rx-only".
- Insulin_glulisine medlineplus "a607033".
- Insulin_glulisine molecularWeight "5823".
- Insulin_glulisine n "64".
- Insulin_glulisine o "78".
- Insulin_glulisine pregnancyUs "C".
- Insulin_glulisine routesOfAdministration "Subcutaneous".
- Insulin_glulisine s "6".
- Insulin_glulisine tradename "Apidra".
- Insulin_glulisine unii "7".
- Insulin_glulisine verifiedfields "changed".
- Insulin_glulisine verifiedrevid "458271650".
- Insulin_glulisine watchedfields "changed".
- Insulin_glulisine wikiPageUsesTemplate Template:Cascite.
- Insulin_glulisine wikiPageUsesTemplate Template:Chemspidercite.
- Insulin_glulisine wikiPageUsesTemplate Template:Drugbankcite.
- Insulin_glulisine wikiPageUsesTemplate Template:Drugbox.
- Insulin_glulisine wikiPageUsesTemplate Template:Drugs.com.
- Insulin_glulisine wikiPageUsesTemplate Template:Expert-subject.
- Insulin_glulisine wikiPageUsesTemplate Template:Fdacite.
- Insulin_glulisine wikiPageUsesTemplate Template:Gastrointestinal-drug-stub.
- Insulin_glulisine wikiPageUsesTemplate Template:Keggcite.
- Insulin_glulisine wikiPageUsesTemplate Template:Oral_hypoglycemics_and_insulin_analogs.
- Insulin_glulisine wikiPageUsesTemplate Template:Peptidergics.
- Insulin_glulisine wikiPageUsesTemplate Template:Reflist.
- Insulin_glulisine subject Category:Insulin_therapies.
- Insulin_glulisine hypernym Analogue.
- Insulin_glulisine type ChemicalSubstance.
- Insulin_glulisine type Drug.
- Insulin_glulisine type Chemical.
- Insulin_glulisine type Drug.
- Insulin_glulisine type Redirect.
- Insulin_glulisine type ChemicalObject.
- Insulin_glulisine type Thing.
- Insulin_glulisine type Q8386.
- Insulin_glulisine comment "Insulin glulisine is a rapid-acting insulin analogue that differs from human insulin in that the amino acid asparagine at position B3 is replaced by lysine and the lysine in position B29 is replaced by glutamic acid. It was developed by Sanofi-Aventis and sold under the trade name Apidra. When injected subcutaneously, it appears in the blood earlier than human insulin. When used as a meal time insulin, the dose is given within 15 minutes before a meal or within 20 minutes after starting a meal.".
- Insulin_glulisine label "Insulin glulisine".
- Insulin_glulisine sameAs Q6042242.
- Insulin_glulisine sameAs أنسولين_غلوليزين.
- Insulin_glulisine sameAs m.02pr6x4.
- Insulin_glulisine sameAs Insulin_glulizin.
- Insulin_glulisine sameAs Insulin_glulizin.
- Insulin_glulisine sameAs Q6042242.
- Insulin_glulisine wasDerivedFrom Insulin_glulisine?oldid=691441090.
- Insulin_glulisine isPrimaryTopicOf Insulin_glulisine.